Canlyniadau Chwilio - D. Geft
- Dangos 1 - 2 canlyniadau o 2
-
1
Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients gan J. Patel, Guillaume Coutance, Alexandre Loupy, Deanna Dilibero, Michèle A. Hamilton, M. Kittleson, E. Kransdorf, Babak Azarbal, Osamu Seguchi, Xiaohai Zhang, D. Chang, D. Geft, L. Czer, Shaïda Varnous, Jon Kobashigawa
Cyhoeddwyd 2020Artigo -
2
Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization gan Andriana Nikolova, Tara C. Hitzeman, Rachel Baum, Ana-Maria Caldaruse, Sosse Agvanian, Yu Xie, D. Geft, D. Chang, J. Moriguchi, A. Hage, Babak Azarbal, L. Czer, M. Kittleson, J. Patel, Alan H.B. Wu, J. Kobashigawa, Michèle A. Hamilton, TingTing Hong, Robin M. Shaw
Cyhoeddwyd 2018Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Internal medicine
Medicine
Antibody
Biochemistry
Biomarker
Cardiology
Chemistry
Clinical endpoint
Cohort
Complement system
Eculizumab
Ejection fraction
Gastroenterology
Heart failure
Heart failure with preserved ejection fraction
Heart transplantation
Immunology
Kidney transplantation
Natriuretic peptide
Panel reactive antibody
Randomized controlled trial
Surgery
Surrogate endpoint
Transplantation